Original Research
Accepted on 25 Feb 2026
A Multi-Database Pharmacovigilance Study Reveals Distinctive Immunosuppressive and Opportunistic Infection Disproportionality Signals with Bevacizumab and Temozolomide Combination Therapy in Glioblastoma
in Regulatory Science